Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & COO

SVP, Chief Accounting Officer

EVP & Chief Legal Officer

Chairman & CEO

SVP, Head of Europe & Internat

EVP, Global Head of R&D

EVP & Chief Financial Officer

SVP, Technical Operations

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, such as hematologic and solid tumors. Its lead marketed products in neuroscience include Xywav, an oral solution for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy and idiopathic hypersomnia (IH); Xyrem, a sodium oxybate oral solution for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older; and Epidiolex, a cannabidiol oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in patients one year of age or older. The company's lead marketed products in oncology comprise Zepzelca for the treatment of adult patients with metastatic small cell lung cancer; Rylaze, a product for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adults and pediatric patients aged one month or older who has developed hypersensitivity to E. coli-derived asparaginase; Vyxeos, a liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease with renal or pulmonary dysfunction following hematopoietic stem cell transplantation. It has licensing and collaboration agreements with Zymeworks Inc.; Sumitomo Pharma Co., Ltd; Werewolf Therapeutics, Inc.; Codiak BioSciences, Inc.; Ligand Pharmaceuticals Incorporated; XL-protein GmbH; and Redx Pharma plc. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-05	Premium	sold (taxes)	Premium	Premium	Premium	President & COO
2024-03-07	Premium	sold	Premium	Premium	Premium	SVP, Chief Accounting Officer
2024-03-06	Premium	sold	Premium	Premium	Premium	SVP, Chief Accounting Officer
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	EVP & Chief Legal Officer
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	Chairman & CEO
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Head of Europe & Internat
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Global Head of R&D
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	President & COO
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, Chief Accounting Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	-
2024-03-01	Premium	acquired	Premium	Premium	Premium	EVP & Chief Financial Officer
2024-03-01	Premium	bought	Premium	Premium	Premium	EVP & Chief Financial Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, Head of Europe & Internat
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chairman & CEO
2024-03-01	Premium	acquired	Premium	Premium	Premium	President & COO
2024-03-01	Premium	acquired	Premium	Premium	Premium	SVP, Technical Operations
2024-03-01	Premium	acquired	Premium	Premium	Premium	EVP, Global Head of R&D
2024-03-01	Premium	acquired	Premium	Premium	Premium	EVP & Chief Legal Officer
2024-01-17	Premium	acquired	Premium	Premium	Premium	Chairman & CEO
2024-01-17	Premium	acquired	Premium	Premium	Premium	EVP & Chief Legal Officer
2024-01-17	Premium	acquired	Premium	Premium	Premium	President & COO
2024-01-17	Premium	sold (taxes)	Premium	Premium	Premium	Chairman & CEO
2024-01-17	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Head of Europe & Internat
2024-01-17	Premium	acquired	Premium	Premium	Premium	SVP, Chief Accounting Officer
2024-01-17	Premium	acquired	Premium	Premium	Premium	SVP, Head of Europe & Internat

JAZZ - Jazz Pharmaceuticals PLC Stock Price, Fair Value and News

Latest Insider Trading transactions for JAZZ